The prevalence of antibodies to simian T-cell leukaemia/lymphotropic virus (STLV-I) in non-human primate colonies in Kenya
Authors:
J. M. Mwenda;
M. W. Sichangi;
M. Isahakia;
E. J. Van Rensburg; D. K. Langat
DOI:
10.1080/00034989958555
Publication Frequency:
8 issues per year
Published in:
Annals of Tropical Medicine and Parasitology,
Volume
93,
Issue
3
April
1999
, pages 289
- 297
Formats available:
PDF
(English)
The circumstances under which this title is published have changed:
Reason for change: Changed Publisher
Now published by: Maney Publishing
Date of change: 2002
View Article:
View Article (PDF)
Abstract
Retroviruses closely related to the human T-cell leukaemia/lymphotrophic virus type I (HTLV-I) have been detected in several, non-human, primate species. These retroviruses are called simian Tlymphotrophic virus type I (STLV-I). Infection with STLV-I has been associated with lymphoma and leukaemia in macaques, baboons, African green monkeys and gorillas. However, no STLV-I infection has been detected in New World primates, although STLV-II has been detected in spider monkeys. When sera from 10 species of non-human primates maintained at the Institute of Primate Research were screened for STLV-I infection, anti-STLV-I antibodies were detected in 12%, 12%, 23% and 38% of the olive baboons, yellow baboons, African green monkeys and lowland Sykes' monkeys, respectively. Western-blot studies confirmed these results. To date, no clinical disease has been linked with STLV-I infection in these colonies. The relatively high prevalence of anti-STLV-I antibodies in these non-human primates offers an opportunity for studies on the transmission, phylogenetic relationships and natural history of STLV-I in primate colonies.
|

Download Citation
CiteULike
Del.icio.us
BibSonomy
Connotea